info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Dasatinib (Sprycel)
502
Article source: Seagull Pharmacy
Nov 03, 2025

Dasatinib (Sprycel) is a multi-targeted inhibitor against tyrosine kinases, which exerts anti-cancer effects by blocking multiple key tumor signaling pathways. With its unique "dual mechanism", it can not only act on the active conformation of ABL kinase but also bind to the inactive conformation, thereby effectively overcoming a variety of imatinib-resistant mutations.

Indications for Dasatinib (Sprycel)

Indications for Adult Patients

Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Patients with chronic phase, accelerated phase, or blast phase (myeloid or lymphoid) CML who are resistant or intolerant to previous treatments (including imatinib).

Patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who are resistant or intolerant to previous treatments.

Indications for Pediatric Patients (Children Aged 1 Year and Older)

Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), which needs to be used in combination with chemotherapy.

Specifications and Properties of Dasatinib (Sprycel)

Appearance Characteristics

All tablets are white to off-white, biconvex, film-coated tablets.

20 mg: Round tablets, engraved with "BMS" on one side and "527" on the other side.

50 mg: Oval tablets, engraved with "BMS" on one side and "528" on the other side.

100 mg: Oval tablets, engraved with "BMS100" on one side and "852" on the other side.

The tablet core contains the active ingredient dasatinib, and the outer layer is coated with a film to reduce the risk of exposure for healthcare workers.

Storage Conditions for Dasatinib (Sprycel)

General Storage Requirements

Storage temperature: 20°C to 25°C (68°F to 77°F).

Short-term storage in an environment of 15°C to 30°C (59°F to 86°F) is permitted.

Precautions for Special Operations

Prohibition of crushing operations: Tablets must not be crushed, split, or chewed; they must be swallowed whole.

Safety Protection Measures

Latex or nitrile gloves must be worn when handling crushed tablets.

Pregnant individuals should avoid contact with broken tablets.

Special disposal procedures must be followed when discarding expired medications.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Dasatinib (Sprycel)
Dasatinib (Sprycel) is a kinase inhibitor primarily used for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). As this prod...
What Are the Side Effects of Tacrolimus Capsules (Astagraf XL)?
Tacrolimus Capsules (Astagraf XL) are key immunosuppressants for preventing organ rejection after kidney transplantation. The safety of their use and risk management are directly related to patients&#...
Precautions for Taking Tacrolimus Capsules (Astagraf XL)
Tacrolimus Capsules (Astagraf XL) are a type of calcineurin inhibitor immunosuppressant, primarily used in kidney transplant patients to prevent organ rejection.Precautions for Taking Tacrolimus Capsu...
How to Use Tacrolimus Capsules (Astagraf XL)
Tacrolimus Capsules (Astagraf XL) are calcineurin inhibitor-type immunosuppressants used in kidney transplant patients to prevent organ rejection. To optimize therapeutic efficacy and reduce the risk ...
How to Use Dasatinib (Sprycel)
Dasatinib (Sprycel) is a targeted drug belonging to the class of kinase inhibitors, primarily used for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute ...
Precautions for Taking Dasatinib (Sprycel)
Dasatinib (Sprycel) is a targeted therapeutic drug belonging to the class of kinase inhibitors, primarily used for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML...
What Are the Side Effects of Dasatinib (Sprycel)?
Dasatinib (Sprycel) is a second-generation tyrosine kinase inhibitor that plays a crucial role in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Philadelphi...
How to Purchase Amlodipine
Amlodipine is a long-acting calcium channel blocker primarily used in the treatment of hypertension and coronary artery diseases such as chronic stable angina and vasospastic angina. As a prescription...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved